Shopping Cart
Remove All
Your shopping cart is currently empty
Ipsoprubart
😃Good
Catalog No. T9901A-1881Cas No. 3035552-25-8
Ipsoprubart is a humanized IgG1κ antibody targeting SIRPa/CD172a, with its corresponding isotype control being HumanIgG1kappa, Isotype Control.
Ipsoprubart
Ipsoprubart
😃Good
Catalog No. T9901A-1881Cas No. 3035552-25-8
Ipsoprubart is a humanized IgG1κ antibody targeting SIRPa/CD172a, with its corresponding isotype control being HumanIgG1kappa, Isotype Control.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Ipsoprubart is a humanized IgG1κ antibody targeting SIRPa/CD172a, with its corresponding isotype control being HumanIgG1kappa, Isotype Control. |
| Cas No. | 3035552-25-8 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Ipsoprubart | purchase Ipsoprubart | Ipsoprubart cost | order Ipsoprubart
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.